Log In
Print
BCIQ
Print
Print this Print this
 

Replagal, agalsidase alfa

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionInjectable alpha galactosidase A enzyme
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentMarketed
IndicationFabry's disease
Partner

Dainippon Sumitomo Pharma Co. Ltd.; Paladin Labs Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today